OTC:TEVJF | Buybacks | TEVA PHARMACEUTICAL INDUSTRIES LTD

TEVJF Buybacks

23 quarter-specific issuer repurchase-cash observations normalized from SEC filings, newest first. A filed zero remains visible; a missing filing fact is never converted into zero. This page shows rows 1–23; provenance stays internal.

Issuer profilePeriod endTypeReported cash
TEVA PHARMACEUTICAL INDUSTRIES LTD2016-12-31Reported repurchase cash$0.00
TEVA PHARMACEUTICAL INDUSTRIES LTD2016-03-31Reported repurchase cash$0.00
TEVA PHARMACEUTICAL INDUSTRIES LTD2015-12-31Reported repurchase cash$0.00
TEVA PHARMACEUTICAL INDUSTRIES LTD2015-03-31Reported repurchase cash$439M
TEVA PHARMACEUTICAL INDUSTRIES LTD2014-12-31Reported repurchase cash$500M
TEVA PHARMACEUTICAL INDUSTRIES LTD2014-09-30Reported repurchase cash$0.00
TEVA PHARMACEUTICAL INDUSTRIES LTD2014-06-30Reported repurchase cash$0.00
TEVA PHARMACEUTICAL INDUSTRIES LTD2014-03-31Reported repurchase cash$0.00
TEVA PHARMACEUTICAL INDUSTRIES LTD2013-12-31Reported repurchase cash$0.00
TEVA PHARMACEUTICAL INDUSTRIES LTD2013-09-30Reported repurchase cash$0.00
TEVA PHARMACEUTICAL INDUSTRIES LTD2013-06-30Reported repurchase cash$297M
TEVA PHARMACEUTICAL INDUSTRIES LTD2013-04-01Reported repurchase cash$200M
TEVA PHARMACEUTICAL INDUSTRIES LTD2013-03-31Reported repurchase cash$200M
TEVA PHARMACEUTICAL INDUSTRIES LTD2012-12-31Reported repurchase cash$494M
TEVA PHARMACEUTICAL INDUSTRIES LTD2012-09-30Reported repurchase cash$0.00
TEVA PHARMACEUTICAL INDUSTRIES LTD2012-06-30Reported repurchase cash$134M
TEVA PHARMACEUTICAL INDUSTRIES LTD2012-03-31Reported repurchase cash$134M
TEVA PHARMACEUTICAL INDUSTRIES LTD2011-12-31Reported repurchase cash$150M
TEVA PHARMACEUTICAL INDUSTRIES LTD2011-09-30Reported repurchase cash$254M
TEVA PHARMACEUTICAL INDUSTRIES LTD2011-06-30Reported repurchase cash$95M
TEVA PHARMACEUTICAL INDUSTRIES LTD2011-03-31Reported repurchase cash$400M
TEVA PHARMACEUTICAL INDUSTRIES LTD2010-12-31Reported repurchase cash$99M
TEVA PHARMACEUTICAL INDUSTRIES LTD2010-03-31Reported repurchase cash$0.00

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.